MCID: URT024
MIFTS: 23

Urethra Clear Cell Adenocarcinoma malady

Categories: Cancer diseases

Aliases & Classifications for Urethra Clear Cell Adenocarcinoma

Aliases & Descriptions for Urethra Clear Cell Adenocarcinoma:

Name: Urethra Clear Cell Adenocarcinoma 12 14
Clear Cell Adenocarcinoma of the Urethra 12
Urethral Clear Cell Adenocarcinoma 69

Classifications:



External Ids:

Disease Ontology 12 DOID:5307
NCIt 47 C6172
UMLS 69 C1336886

Summaries for Urethra Clear Cell Adenocarcinoma

MalaCards based summary : Urethra Clear Cell Adenocarcinoma, also known as clear cell adenocarcinoma of the urethra, is related to adenocarcinoma and clear cell adenocarcinoma. An important gene associated with Urethra Clear Cell Adenocarcinoma is FNDC3B (Fibronectin Type III Domain Containing 3B), and among its related pathways/superpathways is Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex. The drugs Fentanyl and pancreatic polypeptide have been mentioned in the context of this disorder. Related phenotypes are homeostasis/metabolism and mortality/aging

Related Diseases for Urethra Clear Cell Adenocarcinoma

Graphical network of the top 20 diseases related to Urethra Clear Cell Adenocarcinoma:



Diseases related to Urethra Clear Cell Adenocarcinoma

Symptoms & Phenotypes for Urethra Clear Cell Adenocarcinoma

MGI Mouse Phenotypes related to Urethra Clear Cell Adenocarcinoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.61 ALK AMACR APP ARID2 ATM FNDC3B
2 mortality/aging MP:0010768 9.23 ALK AMACR APP ARID2 ATM FNDC3B

Drugs & Therapeutics for Urethra Clear Cell Adenocarcinoma

Drugs for Urethra Clear Cell Adenocarcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 24)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2 pancreatic polypeptide Phase 3
3 Analgesics Phase 3
4 Adjuvants, Anesthesia Phase 3
5 Narcotics Phase 3
6 Analgesics, Opioid Phase 3
7 Anesthetics Phase 3
8 Anesthetics, General Phase 3
9 Anesthetics, Intravenous Phase 3
10 Peripheral Nervous System Agents Phase 3
11 Liver Extracts Phase 3,Phase 1
12 Central Nervous System Depressants Phase 3
13 Cola Nutraceutical Phase 3,Phase 1
14
nivolumab Approved Phase 1 946414-94-4
15
Docetaxel Approved May 1996, Investigational Phase 1 114977-28-5 148124 9877265
16 Angiogenesis Inhibitors Phase 1
17 Angiogenesis Modulating Agents Phase 1
18 Anti-Bacterial Agents Phase 1
19 Anti-Infective Agents Phase 1
20 Immunosuppressive Agents Phase 1
21 Antimitotic Agents Phase 1
22 Immunoglobulins Phase 1
23 Antibodies, Monoclonal Phase 1
24 Antibodies Phase 1

Interventional clinical trials:


id Name Status NCT ID Phase
1 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
2 Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Not yet recruiting NCT03170960 Phase 1, Phase 2
3 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1
4 Cabozantinib-s-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Recruiting NCT02496208 Phase 1
5 Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients Completed NCT00253383

Search NIH Clinical Center for Urethra Clear Cell Adenocarcinoma

Genetic Tests for Urethra Clear Cell Adenocarcinoma

Anatomical Context for Urethra Clear Cell Adenocarcinoma

Publications for Urethra Clear Cell Adenocarcinoma

Variations for Urethra Clear Cell Adenocarcinoma

Expression for Urethra Clear Cell Adenocarcinoma

Search GEO for disease gene expression data for Urethra Clear Cell Adenocarcinoma.

Pathways for Urethra Clear Cell Adenocarcinoma

Pathways related to Urethra Clear Cell Adenocarcinoma according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 9.97 ATM SMAD4

GO Terms for Urethra Clear Cell Adenocarcinoma

Biological processes related to Urethra Clear Cell Adenocarcinoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 regulation of apoptotic process GO:0042981 9.43 ALK ATM PAX8
2 ovarian follicle development GO:0001541 9.37 ATM SMAD4
3 branching involved in ureteric bud morphogenesis GO:0001658 9.32 PAX8 SMAD4
4 neuron apoptotic process GO:0051402 9.16 APP ATM
5 female gonad development GO:0008585 8.96 ATM SMAD4
6 kidney development GO:0001822 8.8 PAX8 SMAD4 UPK3A

Sources for Urethra Clear Cell Adenocarcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....